Jian Wang

Dr. Jian Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2024 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
ZGZiming Guo
Ziming Guo
YDYi Du
Yi Du
JZJun Zhao
Jun Zhao
SSSha Sha
Sha Sha
JWJian Wang
Jian Wang
Background: The development of novel therapies holds significance in improving the prognosis of ovarian cancer (OC). This study aimed to prepare 177Lu-FA-DOTA-PEG-PLGA nanoparticles and evaluate their antitumor efficacy in OC. Methods: To obtain nanoparticles with both targeting and degradable properties, we employed folate receptor (FR) as the targeting molecule, the biodegradable material polyethyleneglycol-polylactic acid-co-glycolic acid (PEG-PLGA) as the carrier matrix, and diethylene triamine pentaacetic acid (DOTA) as the metal chelating agent to prepare 177Lu-FA-DOTA-PEG-PLGA nanoparticles. The labeling yield and radiochemical purity were determined. Healthy Institute of Cancer Research (ICR) mice and Bagg albino strain C (BALB/c) nude mice bearing subcutaneously transplanted SKOV3 human OC tumors were given 18.5 Mbq of 177Lu-FA-DOTA-PEG-PLGA nanoparticles for histological distribution analysis and micro-single-photon emission computed tomography/computed tomography (micro-SPECT/CT) imaging, respectively. Twelve BALB/c nude mice bearing subcutaneously transplanted tumors or 12 BALB/c nude mice bearing intraperitoneal metastatic tumors were assigned to control (received 0.1 mL saline solution), chemotherapy (received twice 3 mg/kg cisplatin per week), and nanoparticle groups (received 18.5 Mbq nanoparticles via tail vein or intraperitoneal injection) (n = 4 per group). Tumor growth inhibition (TGI) and ascitic fluid volume were calculated to investigate antitumor efficiency. Hematoxylin and eosin (HE) staining was performed to evaluate the safety of nanoparticles. Results: The 177Lu-FA-DOTA-PEG-PLGA nanoparticles (labeling yield: 97–98%; radiochemical purity: 96–98%) exhibited a long blood circulation time and a low renal radioactivity uptake (1.646 %ID/g). Micro-SPECT/CT imaging revealed the highest tumor-to-muscle uptake ratio of 2.81 at 24 h. After tail vein injection of nanoparticles, the tumor growth in the chemotherapy and nanoparticle groups was inhibited compared with the control group. Upon intraperitoneal injection, fluorescence intensities of intraperitoneal metastatic tumors in the control, chemotherapy and nanoparticle groups showed a statistical difference (F = 6.09, p = 0.029). Ascitic fluid volumes in the chemotherapy and nanoparticle groups were significantly lower than that in the control group (F = 13.43, p = 0.006). HE staining results showed no obvious abnormalities in the small intestine and colon tissues of the mice in the nanoparticle group compared to the control group. Conclusions: We successfully developed 177Lu-FA-DOTA-PEG-PLGA nanoparticles with a long blood circulation time and low renal radioactivity uptake. These nanoparticles could inhibit OC tumor growth and intraperitoneal metastasis, suggesting a potential novel therapy for OC patients.

1 July 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
JWJian Wang
Jian Wang
ZGZiming Guo
Ziming Guo
FSFei Sun
Fei Sun
TXTian Xu
Tian Xu
JWJianlin Wang
Jianlin Wang
JYJingping Yu
Jingping Yu
Objective. This study aimed to develop a novel ferroptosis-related gene-based prognostic signature for esophageal carcinoma (ESCA). Methods. The TCGA-ESCA gene expression profiles and corresponding clinical data were downloaded from the TCGA database. Ferroptosis-related genes were identified from the literature and public databases, which were intersected with the differentially expressed genes between ESCA and normal samples. After univariate Cox regression and random forest analyses, several ferroptosis-related feature genes were identified and used to construct a prognostic signature. Then, the prognostic value of the complex value and the correlation of the complex value with immune cell infiltration were analyzed. Moreover, function analysis, mutation analysis, and molecular docking on the ferroptosis-related feature genes were performed. Results. Based on the TCGA dataset and ferroptosis pathway genes, 1929 ferroptosis-related genes were preliminarily selected. Following univariate Cox regression analysis and survival analysis, 14 genes were obtained. Then, random forest analysis identified 10 ferroptosis key genes. These 10 genes were used to construct a prognostic complex value. It was found that low complex value indicated better prognosis compared with high complex value. In different ESCA datasets, there were similar differences in the proportion of immune cell distribution between the high and low complex value groups. Furthermore, TNKS1BP1, AC019100.7, KRI1, BCAP31, and RP11-408E5.5 were significantly correlated with ESCA tumor location, lymph node metastasis, and age of patients. KRI1 had the highest mutation frequency. BCAP31 had the strongest binding ability with small molecules DB12830, DB05812, and DB07307. Conclusion. We constructed a novel ferroptosis-related gene signature, which has the potential to predict patient survival and tumor-infiltrating immune cells of ESCA.